Vir Biotechnology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	232.19	222.95	241.58	848.63	347.82
Short-Term Investments	234.83	682.4	1,281	1,553	360.33
Cash & Short-Term Investments	467.02	905.35	1,522	2,402	708.15
Cash Growth	-48.42%	-40.53%	-36.62%	239.20%	-3.90%
Other Receivables	-	-	-	-	773.08
Total Trade Receivables	-	-	-	-	773.08
Other Current Assets	47.07	137.11	65.82	117.04	81.6
Total Current Assets	514.08	1,042	1,588	2,519	1,563
Net Property, Plant & Equipment	117.72	122.86	167.2	188.17	130.05
Other Intangible Assets	7.85	8.12	22.57	32.76	33.29
Goodwill	16.94	16.94	16.94	16.94	16.94
Long-Term Investments	314.58	190.02	105.28	23.93	201.39
Other Long-Term Assets	31.66	18.42	18.86	21.23	9.78
Total Assets	1,003	1,399	1,919	2,802	1,954
Accounts Payable	9.8	5.08	6.33	6.42	6.52
Accrued Expenses	83.01	98.52	104.22	489.09	236.51
Unearned Revenue	-	-	64.85	15.52	98.21
Other Current Liabilities	-	16.06	-	-	-
Total Current Liabilities	92.82	119.66	175.41	511.03	341.24
Long-Term Leases	89.05	90.14	111.67	123.84	133.56
Other Long-Term Liabilities	55.68	38.63	41.74	89.26	47.62
Total Long-Term Liabilities	144.73	128.77	153.42	213.1	181.18
Total Liabilities	237.55	248.43	328.82	724.13	522.42
Common Stock	0.01	0.01	0.01	0.01	0.01
Additional Paid-in Capital	1,965	1,912	1,829	1,710	1,572
Accumulated Other Comprehensive Income	-2.06	-1.72	-0.82	-9.12	-1.1
Retained Earnings	-	-	-237.82	377.24	-138.6
Shareholders' Equity	1,963	1,910	1,590	2,078	1,432
Total Liabilities & Equity	1,003	1,399	1,919	2,802	1,954
Total Debt	89.05	90.14	111.67	123.84	133.56
Net Cash (Debt)	377.96	815.21	1,411	2,278	574.58
Net Cash Growth	-53.64%	-42.21%	-38.08%	296.50%	-14.28%
Net Cash Per Share	2.73	5.98	10.52	16.90	4.31
Book Value	1,963	1,910	1,590	2,078	1,432
Book Value Per Share	14.17	14.02	11.86	15.41	10.73
Tangible Book Value	1,938	1,885	1,551	2,028	1,382
Tangible Book Value Per Share	13.99	13.84	11.56	15.05	10.35

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q